Tempus AI shares rated Buy by Loop Capital, target cut as Compass CRO softness weighs on guidance

Published 14/01/2025, 13:44
Tempus AI shares rated Buy by Loop Capital, target cut as Compass CRO softness weighs on guidance

Tuesday, Tempus AI Inc (NASDAQ:TEM) shares were in focus after Loop Capital adjusted its price target on the company. Analysts at Loop Capital trimmed the price target to $52.00 from $57.00, while sustaining a Buy rating on the stock. The revised target follows Tempus AI's disclosure of preliminary fourth-quarter 2024 total revenues that fell short of both Loop Capital's and Wall Street's expectations.

The company reported that it anticipates total revenues of approximately $200 million, which reflects an estimated 35% growth. This figure is below the previously projected revenues of $207 million by Loop Capital and $206 million by the consensus. As a result, the full-year 2024 revenue guidance has been adjusted to $693 million, which is beneath the $700 million forecast set earlier in the year by Tempus AI management.

Despite the shortfall in the Compass Contract Research Organization (CRO) business, which the firm considers non-core, Tempus AI expects to see about 30% growth in its genomics business and around 45% growth in its data & services business. The company has not provided detailed profitability guidance but anticipates a sequential improvement in Adjusted EBITDA for the fourth quarter.

Loop Capital has also revised its fourth-quarter revenue estimate for Tempus AI to $200.5 million, which adjusts the full-year projection to $700 million, indicating a 30% annual growth. These estimates do not account for the pending acquisition of Ambry Genetics, which is expected to be completed in the first quarter of 2025.

The decision to lower the price target was influenced by the revised revenue estimates and the recent compression in market multiples, as explained by Loop Capital. Nevertheless, the firm remains optimistic about Tempus AI's prospects, as reflected in the reiterated Buy rating.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.